These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3170575)

  • 21. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
    Marchi RC; Carvajal Z; Boyer-Neumann C; Anglés-Cano E; Weisel JW
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigations of fibrin clots formation under the effect of thrombin and ancystron].
    Savchuk OM; Chernyshov VI; Volkov HL
    Ukr Biokhim Zh (1999); 2004; 76(3):122-5. PubMed ID: 19621750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant fibrinogen, gamma275Arg-->Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions.
    Ishikawa S; Hirota-Kawadobora M; Tozuka M; Ishii K; Terasawa F; Okumura N
    J Thromb Haemost; 2004 Mar; 2(3):468-75. PubMed ID: 15009465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.
    Collet JP; Moen JL; Veklich YI; Gorkun OV; Lord ST; Montalescot G; Weisel JW
    Blood; 2005 Dec; 106(12):3824-30. PubMed ID: 16091450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
    Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
    J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin).
    Mosesson MW; DiOrio JP; Müller MF; Shainoff JR; Siebenlist KR; Amrani DL; Homandberg GA; Soria J; Soria C; Samama M
    Blood; 1987 Apr; 69(4):1073-81. PubMed ID: 3548843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mutation (deletion of Aalpha-Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot.
    Marchi RC; Meyer MH; de Bosch NB; Arocha-Piñango CL; Weisel JW
    Blood Coagul Fibrinolysis; 2004 Oct; 15(7):559-67. PubMed ID: 15389122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ultrastructure of fibrinogen-420 and the fibrin-420 clot.
    Mosesson MW; DiOrio JP; Hernandez I; Hainfeld JF; Wall JS; Grieninger G
    Biophys Chem; 2004 Dec; 112(2-3):209-14. PubMed ID: 15572250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand.
    Antovic A; Mikovic D; Elezovic I; Zabczyk M; Hutenby K; Antovic JP
    Thromb Haemost; 2014 Apr; 111(4):656-61. PubMed ID: 24258360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides.
    Weisel JW
    Biophys J; 1986 Dec; 50(6):1079-93. PubMed ID: 3801570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biophysical characterization of fibrinogen Caracas I with an Aalpha-chain truncation at Aalpha-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen.
    Marchi R; Meyer M; de Bosch N; Soria J; Arocha-Piñango CL; Weisel JW
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):285-93. PubMed ID: 15166913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
    Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
    Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition.
    Glover CJ; McIntire LV; Brown CH; Natelson EA
    J Lab Clin Med; 1975 Oct; 86(4):644-56. PubMed ID: 1176815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coarse-grained molecular dynamics simulations of fibrin polymerization: effects of thrombin concentration on fibrin clot structure.
    Yesudasan S; Wang X; Averett RD
    J Mol Model; 2018 Apr; 24(5):109. PubMed ID: 29623504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Location of the binding site "b" for lateral polymerization of fibrin.
    Hasegawa N; Sasaki S
    Thromb Res; 1990 Jan; 57(2):183-95. PubMed ID: 2315883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant BbetaArg14His fibrinogen implies participation of N-terminus of Bbeta chain in desA fibrin polymerization.
    Moen JL; Gorkun OV; Weisel JW; Lord ST
    Blood; 2003 Oct; 102(7):2466-71. PubMed ID: 12805063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of pH on the generation of turbidity and elasticity associated with fibrinogen-fibrin conversion by thrombin are remarkably influenced by sialic acid in fibrinogen.
    Okude M; Yamanaka A; Akihama S
    Biol Pharm Bull; 1995 Feb; 18(2):203-7. PubMed ID: 7742784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for thrombin enhancement of fibrin polymerization that is independent of its catalytic activity.
    Kaminski M; Siebenlist KR; Mosesson MW
    J Lab Clin Med; 1991 Mar; 117(3):218-25. PubMed ID: 2002278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function.
    Riedelová-Reicheltová Z; Kotlín R; Suttnar J; Geierová V; Riedel T; Májek P; Dyr JE
    Thromb Haemost; 2014 Jan; 111(1):79-87. PubMed ID: 24108601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.